Insmed Inc Sustainability Reports
Insmed Incorporated is a global biopharmaceutical company focused on developing and commercializing therapies for patients with serious and rare diseases. Its primary areas of focus include chronic lung infections and other orphan disease states.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900Q55QAG41CCAC11
FIGI: BBG001S9SKW7
19 reports from 2005 to 2025
